Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance
Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies, today announced its partner, DEKA Research & Development Corp., has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the innovative twiist™ Automated Insulin Delivery (AID)…
Lupin and Birmingham City University Honour Graduates of Master’s Programme in Advancing Diabetes Care
Global pharma major Lupin Limited (Lupin) joined forces withBirmingham City University, UK (BCU) and hosted a convocation ceremony on March 9, 2024, honouringIndian healthcare professionals who completed the Master’s programme in Advancing Diabetes Care. Thisground-breaking course is tailored to empower…
SIBIONICS Announces Participation in the 17th International Conference on Advanced Technologies and Treatments for Diabetes
SIBIONICS, the world’s third-largest continuous glucose monitoring (CGM) brand, announced that it will participate in the International Diabetes Technology Exhibition at the 17th Symposium on Diabetes at the 17th Symposium on Diabetese International Conference on Advanced Technologies and Treatments for Diabetes…
Agilus Diagnostics publishes data study ahead of World Diabetes Day 2023
India has emerged as the diabetes capital of the world with incidence steadily on the rise over the last three decades. The prevalence of diabetes in India stood at 8.9% in 2019 with more than 77 million people with diabetes….
ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore General Hospital-led Study
ALR Technologies SG Ltd. (“ALRT” or the “Company”) (OTCQB: ALRTF), a diabetes management company, announces the patent application titled Method and System of Monitoring a Diabetes Treatment Plan (“Predictive A1c”) has been granted in Singapore and has received notice of…
